Noninvasive Hemodynamic Profiles during Hemodialysis in Patients with and without Heart Failure.

End-stage renal disease Heart failure Hemodialysis Hemodynamics Impedance cardiography

Journal

Cardiorenal medicine
ISSN: 1664-5502
Titre abrégé: Cardiorenal Med
Pays: Switzerland
ID NLM: 101554863

Informations de publication

Date de publication:
2020
Historique:
received: 05 08 2019
accepted: 10 02 2020
pubmed: 9 4 2020
medline: 10 8 2021
entrez: 9 4 2020
Statut: ppublish

Résumé

Although the dynamics of blood pressure (BP) during dialysis provide information related to the control system, the prognosis and relationships between temporal changes in intradialytic hemodynamic regulation, BP, and decreased cardiac function remain largely unclear. Hemodynamic parameters, including heart rate (HR), stroke volume (SV), cardiac index, and systemic vascular resistance index, were recorded using a noninvasive hemodynamic device on a beat-by-beat basis in 40 patients on dialysis who were divided into three groups, i.e., those with and without BP lability and those with heart failure (HF). Statistical measurements, including mean, standard deviation, coefficient of variation (CV), and index of nonrandomness of each hemodynamic parameter were derived from the three different phases divided equally during dialysis and compared using 3×3 two-way mixed-model analysis of variance to determine the effects of the different stages of hemodialysis (HD), cardiac function, and intradialytic changes in BP on the hemodynamic parameters. In addition, multivariate Cox regression was performed to determine the association between the changes in the derived parameters and BP lability. The average SV tended to decrease during HD in all groups (p = 0.041). A significant decrease was observed in the CV of SV between the first two stages of HD in patients with labile BP and HF when compared to those without labile BP (p = 0.037). Significant interactions between group and stage of the index of nonrandomness for HR were also noted; this index was significantly higher in patients without labile BP than in those with labile BP or HF (p = 0.048). A higher difference between the early and middle stages of HD for nonrandomness indexes of HR was an independent predictor of reduced BP lability during HD (HR = 0.844, 95% confidence interval 0.722-0.987, p = 0.034). Increases in the CV of SV and the index of nonrandomness for HR during early-stage HD in response to decreased SV may be associated with better BP control during HD. This finding suggests that patients with more structurally meaningful hemodynamic control have a more favorable cardiovascular outcome.

Sections du résumé

BACKGROUND
Although the dynamics of blood pressure (BP) during dialysis provide information related to the control system, the prognosis and relationships between temporal changes in intradialytic hemodynamic regulation, BP, and decreased cardiac function remain largely unclear.
METHODS
Hemodynamic parameters, including heart rate (HR), stroke volume (SV), cardiac index, and systemic vascular resistance index, were recorded using a noninvasive hemodynamic device on a beat-by-beat basis in 40 patients on dialysis who were divided into three groups, i.e., those with and without BP lability and those with heart failure (HF). Statistical measurements, including mean, standard deviation, coefficient of variation (CV), and index of nonrandomness of each hemodynamic parameter were derived from the three different phases divided equally during dialysis and compared using 3×3 two-way mixed-model analysis of variance to determine the effects of the different stages of hemodialysis (HD), cardiac function, and intradialytic changes in BP on the hemodynamic parameters. In addition, multivariate Cox regression was performed to determine the association between the changes in the derived parameters and BP lability.
RESULTS
The average SV tended to decrease during HD in all groups (p = 0.041). A significant decrease was observed in the CV of SV between the first two stages of HD in patients with labile BP and HF when compared to those without labile BP (p = 0.037). Significant interactions between group and stage of the index of nonrandomness for HR were also noted; this index was significantly higher in patients without labile BP than in those with labile BP or HF (p = 0.048). A higher difference between the early and middle stages of HD for nonrandomness indexes of HR was an independent predictor of reduced BP lability during HD (HR = 0.844, 95% confidence interval 0.722-0.987, p = 0.034).
CONCLUSIONS
Increases in the CV of SV and the index of nonrandomness for HR during early-stage HD in response to decreased SV may be associated with better BP control during HD. This finding suggests that patients with more structurally meaningful hemodynamic control have a more favorable cardiovascular outcome.

Identifiants

pubmed: 32268337
pii: 000506470
doi: 10.1159/000506470
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-256

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Ying-Kuang Lin (YK)

Division of Nephrology, Department of Medicine, Taiwan Landseed International Hospital, Taoyuan City, Taiwan.
Department of Biomedical Sciences and Engineering, National Central University, Taoyuan City, Taiwan.
Center for Biotechnology and Biomedical Engineering, National Central University, Taoyuan City, Taiwan.

Chih-Chin Kao (CC)

Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.

Chi-Ho Tseng (CH)

Department of Biomedical Sciences and Engineering, National Central University, Taoyuan City, Taiwan.
Center for Biotechnology and Biomedical Engineering, National Central University, Taoyuan City, Taiwan.
Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.

Ching-En Hsu (CE)

Department of Biomedical Sciences and Engineering, National Central University, Taoyuan City, Taiwan.

Yi-Je Lin (YJ)

Department of Biomedical Sciences and Engineering, National Central University, Taoyuan City, Taiwan.

You-Chuan Chen (YC)

Department of Biomedical Sciences and Engineering, National Central University, Taoyuan City, Taiwan.

Chen Lin (C)

Department of Biomedical Sciences and Engineering, National Central University, Taoyuan City, Taiwan, dreamtheater.lin@gmail.com.
Center for Biotechnology and Biomedical Engineering, National Central University, Taoyuan City, Taiwan, dreamtheater.lin@gmail.com.

Chun-Yao Huang (CY)

Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, Cardiovascular Research Center, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH